BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 30638982)

  • 1. A PLN nonsense variant causes severe dilated cardiomyopathy in a novel autosomal recessive inheritance mode.
    Li Z; Chen P; Xu J; Yu B; Li X; Wang DW; Wang DW
    Int J Cardiol; 2019 Mar; 279():122-125. PubMed ID: 30638982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholamban immunostaining is a highly sensitive and specific method for diagnosing phospholamban p.Arg14del cardiomyopathy.
    Te Rijdt WP; van der Klooster ZJ; Hoorntje ET; Jongbloed JDH; van der Zwaag PA; Asselbergs FW; Dooijes D; de Boer RA; van Tintelen JP; van den Berg MP; Vink A; Suurmeijer AJH
    Cardiovasc Pathol; 2017; 30():23-26. PubMed ID: 28759816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies.
    Fish M; Shaboodien G; Kraus S; Sliwa K; Seidman CE; Burke MA; Crotti L; Schwartz PJ; Mayosi BM
    Sci Rep; 2016 Feb; 6():22235. PubMed ID: 26917049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The coexistence of a novel WNK1 variant and a copy number variation causes hereditary sensory and autonomic neuropathy type IIA.
    Wang JJ; Yu B; Li Z
    BMC Med Genet; 2019 May; 20(1):91. PubMed ID: 31132985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study in Polish patients with cardiomyopathy emphasizes pathogenicity of phospholamban (PLN) mutations at amino acid position 9 and low penetrance of heterozygous null PLN mutations.
    Truszkowska GT; Bilińska ZT; Kosińska J; Śleszycka J; Rydzanicz M; Sobieszczańska-Małek M; Franaszczyk M; Bilińska M; Stawiński P; Michalak E; Małek ŁA; Chmielewski P; Foss-Nieradko B; Machnicki MM; Stokłosa T; Ponińska J; Szumowski Ł; Grzybowski J; Piwoński J; Drygas W; Zieliński T; Płoski R
    BMC Med Genet; 2015 Apr; 16():21. PubMed ID: 25928149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy.
    Norton N; Li D; Rieder MJ; Siegfried JD; Rampersaud E; Züchner S; Mangos S; Gonzalez-Quintana J; Wang L; McGee S; Reiser J; Martin E; Nickerson DA; Hershberger RE
    Am J Hum Genet; 2011 Mar; 88(3):273-82. PubMed ID: 21353195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes.
    Posch MG; Perrot A; Geier C; Boldt LH; Schmidt G; Lehmkuhl HB; Hetzer R; Dietz R; Gutberlet M; Haverkamp W; Ozcelik C
    Heart Rhythm; 2009 Apr; 6(4):480-6. PubMed ID: 19324307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human.
    Haghighi K; Kolokathis F; Pater L; Lynch RA; Asahi M; Gramolini AO; Fan GC; Tsiapras D; Hahn HS; Adamopoulos S; Liggett SB; Dorn GW; MacLennan DH; Kremastinos DT; Kranias EG
    J Clin Invest; 2003 Mar; 111(6):869-76. PubMed ID: 12639993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy.
    DeWitt MM; MacLeod HM; Soliven B; McNally EM
    J Am Coll Cardiol; 2006 Oct; 48(7):1396-8. PubMed ID: 17010801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetics of dilated cardiomyopathy: a prioritized candidate gene study of LMNA, TNNT2, TCAP, and PLN.
    Hirtle-Lewis M; Desbiens K; Ruel I; Rudzicz N; Genest J; Engert JC; Giannetti N
    Clin Cardiol; 2013 Oct; 36(10):628-33. PubMed ID: 24037902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome sequencing establishes diagnosis of Alström syndrome in an infant presenting with non-syndromic dilated cardiomyopathy.
    Long PA; Evans JM; Olson TM
    Am J Med Genet A; 2015 Apr; 167A(4):886-90. PubMed ID: 25706677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban.
    Schmitt JP; Kamisago M; Asahi M; Li GH; Ahmad F; Mende U; Kranias EG; MacLennan DH; Seidman JG; Seidman CE
    Science; 2003 Feb; 299(5611):1410-3. PubMed ID: 12610310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole exome sequencing identifies a causal RBM20 mutation in a large pedigree with familial dilated cardiomyopathy.
    Wells QS; Becker JR; Su YR; Mosley JD; Weeke P; D'Aoust L; Ausborn NL; Ramirez AH; Pfotenhauer JP; Naftilan AJ; Markham L; Exil V; Roden DM; Hong CC
    Circ Cardiovasc Genet; 2013 Aug; 6(4):317-26. PubMed ID: 23861363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole exome sequencing identified 1 base pair novel deletion in BCL2-associated athanogene 3 (BAG3) gene associated with severe dilated cardiomyopathy (DCM) requiring heart transplant in multiple family members.
    Rafiq MA; Chaudhry A; Care M; Spears DA; Morel CF; Hamilton RM
    Am J Med Genet A; 2017 Mar; 173(3):699-705. PubMed ID: 28211974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)-Related Cardiomyopathy: Development of PLN-R14del-Related Cardiomyopathy.
    Eijgenraam TR; Boogerd CJ; Stege NM; Oliveira Nunes Teixeira V; Dokter MM; Schmidt LE; Yin X; Theofilatos K; Mayr M; van der Meer P; van Rooij E; van der Velden J; Silljé HHW; de Boer RA
    Circ Heart Fail; 2021 Nov; 14(11):e008532. PubMed ID: 34587756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective Evaluation of the Utility of Whole Exome Sequencing in Dilated Cardiomyopathy.
    Ramchand J; Wallis M; Macciocca I; Lynch E; Farouque O; Martyn M; Phelan D; Chong B; Lockwood S; Weintraub R; Thompson T; Trainer A; Zentner D; Vohra J; Chetrit M; Hare DL; James P
    J Am Heart Assoc; 2020 Jan; 9(2):e013346. PubMed ID: 31931689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids.
    Haghighi K; Chen G; Sato Y; Fan GC; He S; Kolokathis F; Pater L; Paraskevaidis I; Jones WK; Dorn GW; Kremastinos DT; Kranias EG
    Hum Mutat; 2008 May; 29(5):640-7. PubMed ID: 18241046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct molecular signature of phospholamban p.Arg14del arrhythmogenic cardiomyopathy.
    Te Rijdt WP; Asimaki A; Jongbloed JDH; Hoorntje ET; Lazzarini E; van der Zwaag PA; de Boer RA; van Tintelen JP; Saffitz JE; van den Berg MP; Suurmeijer AJH
    Cardiovasc Pathol; 2019; 40():2-6. PubMed ID: 30763825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational screening of phospholamban gene in hypertrophic and idiopathic dilated cardiomyopathy and functional study of the PLN -42 C>G mutation.
    Medin M; Hermida-Prieto M; Monserrat L; Laredo R; Rodriguez-Rey JC; Fernandez X; Castro-Beiras A
    Eur J Heart Fail; 2007 Jan; 9(1):37-43. PubMed ID: 16829191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digenic Inheritance of LAMA4 and MYH7 Mutations in Patient with Infantile Dilated Cardiomyopathy.
    Abdallah AM; Carlus SJ; Al-Mazroea AH; Alluqmani M; Almohammadi Y; Bhuiyan ZA; Al-Harbi KM
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30650640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.